Pretreatment of mice with FLT3L increased lung injury during pneumococcal pneumonia, likely through inducing accumulation of proinflammatory dendritic cells (32), and pharmacological inhibition of FLT3 signaling attenuated LPS-induced lung injury and edema in mice (46). This evidence concerns the gene FLT3 and pneumococcal pneumonia.